542 related articles for article (PubMed ID: 26113084)
1. Therapeutic Targeting of the Warburg Effect in Pancreatic Cancer Relies on an Absence of p53 Function.
Rajeshkumar NV; Dutta P; Yabuuchi S; de Wilde RF; Martinez GV; Le A; Kamphorst JJ; Rabinowitz JD; Jain SK; Hidalgo M; Dang CV; Gillies RJ; Maitra A
Cancer Res; 2015 Aug; 75(16):3355-64. PubMed ID: 26113084
[TBL] [Abstract][Full Text] [Related]
2. On-target inhibition of tumor fermentative glycolysis as visualized by hyperpolarized pyruvate.
Seth P; Grant A; Tang J; Vinogradov E; Wang X; Lenkinski R; Sukhatme VP
Neoplasia; 2011 Jan; 13(1):60-71. PubMed ID: 21245941
[TBL] [Abstract][Full Text] [Related]
3. TP53-inducible Glycolysis and Apoptosis Regulator (TIGAR) Metabolically Reprograms Carcinoma and Stromal Cells in Breast Cancer.
Ko YH; Domingo-Vidal M; Roche M; Lin Z; Whitaker-Menezes D; Seifert E; Capparelli C; Tuluc M; Birbe RC; Tassone P; Curry JM; Navarro-Sabaté À; Manzano A; Bartrons R; Caro J; Martinez-Outschoorn U
J Biol Chem; 2016 Dec; 291(51):26291-26303. PubMed ID: 27803158
[TBL] [Abstract][Full Text] [Related]
4. Hyperpolarized [1-
Scroggins BT; Matsuo M; White AO; Saito K; Munasinghe JP; Sourbier C; Yamamoto K; Diaz V; Takakusagi Y; Ichikawa K; Mitchell JB; Krishna MC; Citrin DE
Clin Cancer Res; 2018 Jul; 24(13):3137-3148. PubMed ID: 29599412
[No Abstract] [Full Text] [Related]
5. Combining Hyperpolarized Real-Time Metabolic Imaging and NMR Spectroscopy To Identify Metabolic Biomarkers in Pancreatic Cancer.
Dutta P; Perez MR; Lee J; Kang Y; Pratt M; Salzillo TC; Weygand J; Zacharias NM; Gammon ST; Koay EJ; Kim M; McAllister F; Sen S; Maitra A; Piwnica-Worms D; Fleming JB; Bhattacharya PK
J Proteome Res; 2019 Jul; 18(7):2826-2834. PubMed ID: 31120258
[TBL] [Abstract][Full Text] [Related]
6. Pyruvate-lactate exchange and glucose uptake in human prostate cancer cell models. A study in xenografts and suspensions by hyperpolarized [1-
van Heijster FHA; Heskamp S; Breukels V; Veltien A; Franssen GM; Jansen KCFJ; Boerman OC; Schalken JA; Scheenen TWJ; Heerschap A
NMR Biomed; 2020 Oct; 33(10):e4362. PubMed ID: 32662543
[TBL] [Abstract][Full Text] [Related]
7. Indoleamine 2,3-dioxygenase increases p53 levels in alloreactive human T cells, and both indoleamine 2,3-dioxygenase and p53 suppress glucose uptake, glycolysis and proliferation.
Eleftheriadis T; Pissas G; Antoniadi G; Spanoulis A; Liakopoulos V; Stefanidis I
Int Immunol; 2014 Dec; 26(12):673-84. PubMed ID: 25064493
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of lactate dehydrogenase A induces oxidative stress and inhibits tumor progression.
Le A; Cooper CR; Gouw AM; Dinavahi R; Maitra A; Deck LM; Royer RE; Vander Jagt DL; Semenza GL; Dang CV
Proc Natl Acad Sci U S A; 2010 Feb; 107(5):2037-42. PubMed ID: 20133848
[TBL] [Abstract][Full Text] [Related]
9. Combined hyperpolarized
Hansen AE; Gutte H; Holst P; Johannesen HH; Rahbek S; Clemmensen AE; Larsen MME; Schøier C; Ardenkjaer-Larsen J; Klausen TL; Kristensen AT; Kjaer A
Eur J Radiol; 2018 Jun; 103():6-12. PubMed ID: 29803387
[TBL] [Abstract][Full Text] [Related]
10. GPR55 receptor antagonist decreases glycolytic activity in PANC-1 pancreatic cancer cell line and tumor xenografts.
Bernier M; Catazaro J; Singh NS; Wnorowski A; Boguszewska-Czubara A; Jozwiak K; Powers R; Wainer IW
Int J Cancer; 2017 Nov; 141(10):2131-2142. PubMed ID: 28741686
[TBL] [Abstract][Full Text] [Related]
11. Multi-modality imaging to assess metabolic response to dichloroacetate treatment in tumor models.
Neveu MA; De Preter G; Joudiou N; Bol A; Brender JR; Saito K; Kishimoto S; Grégoire V; Jordan BF; Krishna MC; Feron O; Gallez B
Oncotarget; 2016 Dec; 7(49):81741-81749. PubMed ID: 28082726
[TBL] [Abstract][Full Text] [Related]
12. Lactate dehydrogenase A is overexpressed in pancreatic cancer and promotes the growth of pancreatic cancer cells.
Rong Y; Wu W; Ni X; Kuang T; Jin D; Wang D; Lou W
Tumour Biol; 2013 Jun; 34(3):1523-30. PubMed ID: 23404405
[TBL] [Abstract][Full Text] [Related]
13. FOXM1 promotes the warburg effect and pancreatic cancer progression via transactivation of LDHA expression.
Cui J; Shi M; Xie D; Wei D; Jia Z; Zheng S; Gao Y; Huang S; Xie K
Clin Cancer Res; 2014 May; 20(10):2595-606. PubMed ID: 24634381
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of LDH-A and glutaminase inhibition in vivo by hyperpolarized 13C-pyruvate magnetic resonance spectroscopy of tumors.
Dutta P; Le A; Vander Jagt DL; Tsukamoto T; Martinez GV; Dang CV; Gillies RJ
Cancer Res; 2013 Jul; 73(14):4190-5. PubMed ID: 23722553
[TBL] [Abstract][Full Text] [Related]
15. Two p53-related metabolic regulators, TIGAR and SCO2, contribute to oroxylin A-mediated glucose metabolism in human hepatoma HepG2 cells.
Dai Q; Yin Y; Liu W; Wei L; Zhou Y; Li Z; You Q; Lu N; Guo Q
Int J Biochem Cell Biol; 2013 Jul; 45(7):1468-78. PubMed ID: 23612020
[TBL] [Abstract][Full Text] [Related]
16. Aurora-A mediated phosphorylation of LDHB promotes glycolysis and tumor progression by relieving the substrate-inhibition effect.
Cheng A; Zhang P; Wang B; Yang D; Duan X; Jiang Y; Xu T; Jiang Y; Shi J; Ding C; Wu G; Sang Z; Wu Q; Wang H; Wu M; Zhang Z; Pan X; Pan YY; Gao P; Zhang H; Zhou CZ; Guo J; Yang Z
Nat Commun; 2019 Dec; 10(1):5566. PubMed ID: 31804482
[TBL] [Abstract][Full Text] [Related]
17. Double genetic disruption of lactate dehydrogenases A and B is required to ablate the "Warburg effect" restricting tumor growth to oxidative metabolism.
Ždralević M; Brand A; Di Ianni L; Dettmer K; Reinders J; Singer K; Peter K; Schnell A; Bruss C; Decking SM; Koehl G; Felipe-Abrio B; Durivault J; Bayer P; Evangelista M; O'Brien T; Oefner PJ; Renner K; Pouysségur J; Kreutz M
J Biol Chem; 2018 Oct; 293(41):15947-15961. PubMed ID: 30158244
[TBL] [Abstract][Full Text] [Related]
18. Selective anti-tumor activity of wogonin targeting the Warburg effect through stablizing p53.
Zhao Y; Zhang L; Wu Y; Dai Q; Zhou Y; Li Z; Yang L; Guo Q; Lu N
Pharmacol Res; 2018 Sep; 135():49-59. PubMed ID: 30031170
[TBL] [Abstract][Full Text] [Related]
19. Anti-cancer efficacy of SREBP inhibitor, alone or in combination with docetaxel, in prostate cancer harboring p53 mutations.
Li X; Wu JB; Chung LW; Huang WC
Oncotarget; 2015 Dec; 6(38):41018-32. PubMed ID: 26512780
[TBL] [Abstract][Full Text] [Related]
20. SLC45A4 promotes glycolysis and prevents AMPK/ULK1-induced autophagy in TP53 mutant pancreatic ductal adenocarcinoma.
Chen W; Huang F; Huang J; Li Y; Peng J; Zhuang Y; Huang X; Lu L; Zhu Z; Zhang S
J Gene Med; 2021 Sep; 23(9):e3364. PubMed ID: 34010493
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
